**Question:** Gelle's test is for

A. Assessing peripheral neuropathy in diabetes mellitus
B. Evaluating the severity of peripheral neuropathy
C. Differentiating peripheral neuropathy from radiculopathies
D. Detecting autonomic neuropathy in diabetes mellitus

**Correct Answer:** A. Assessing peripheral neuropathy in diabetes mellitus

**Core Concept:** Gelle's test, also known as the Semmes-Weinstein monofilament test, is a clinical examination tool used to evaluate the sensitivity of the skin in detecting peripheral neuropathy.

**Why the Correct Answer is Right:** Gelle's test primarily assesses the sensitivity of the skin in patients with diabetes mellitus. It helps in diagnosing peripheral neuropathy, which is a common complication of diabetes affecting the nerves in the body. By applying pressure with a calibrated monofilament to specific sites on the patient's body, the examiner can detect a loss of sensation, which could indicate neuropathy.

**Why Each Wrong Option is Incorrect:**

B. Evaluating the severity of peripheral neuropathy: Although Gelle's test can indirectly provide information about neuropathy, it does not directly assess the severity of the condition. Other tests, such as nerve conduction studies or electromyography, are more suitable for assessing the severity of neuropathy.

C. Differentiating peripheral neuropathy from radiculopathies: Gelle's test primarily focuses on assessing the sensitivity of the skin and does not differentiate between neuropathies and radiculopathies. Different tests, like sensory nerve conduction studies, are more suitable for diagnosing radiculopathies.

D. Detecting autonomic neuropathy in diabetes mellitus: Gelle's test primarily assesses the sensitivity of the skin and is not specific to autonomic neuropathy. Autonomic neuropathy requires more targeted tests like a heart rate variability test, blood pressure response test, or a Valsalva maneuver test to evaluate cardiovascular and gastrointestinal autonomic functions.

**Clinical Pearl:** Gelle's test is a valuable tool to screen for peripheral neuropathy in high-risk patients, such as those with diabetes mellitus. The test helps identify patients who may benefit from further evaluation, but it is essential to combine the results with other tests to make an accurate diagnosis and plan the appropriate management for patients.